Red light therapy, specifically near-infrared light at around 830 nm, has shown promising results for improving thyroid function in people with autoimmune thyroiditis (Hashimoto’s). Clinical trials have found it can reduce thyroid antibody levels, improve hormone output, and in some cases lower the amount of thyroid medication patients need. Here’s what the research says about how to use it effectively.
What Red Light Therapy Does to the Thyroid
Near-infrared light in the 800 to 900 nm range penetrates the skin and reaches underlying tissue. The neck’s skin is relatively thin, averaging about 1.5 mm, which makes it easier for light at these wavelengths to reach the thyroid gland compared to thicker-skinned areas like the cheeks. Once absorbed by thyroid cells, the light energy stimulates activity in the mitochondria, the energy-producing structures inside each cell. This boost in cellular energy appears to improve how well the gland produces hormones.
In autoimmune thyroiditis specifically, the therapy also seems to calm the immune attack on the gland. A study on 42 patients with autoimmune thyroiditis found that autoimmune responses normalized in 78% of participants after four months of treatment. The therapy promotes the release of an anti-inflammatory signaling molecule (TGF-β), which may help explain why the immune system becomes less aggressive toward the thyroid tissue over time.
What the Clinical Evidence Shows
The strongest evidence comes from studies on Hashimoto’s thyroiditis, the most common cause of hypothyroidism. In a pilot study of patients with chronic autoimmune thyroiditis, TPO antibody levels (the primary marker of autoimmune thyroid attack) dropped significantly: from an average of 982 U/ml before treatment to 579 U/ml afterward. That’s roughly a 40% reduction. Patients also needed less levothyroxine to maintain normal thyroid function, and the texture of their thyroid tissue improved on ultrasound.
A randomized, placebo-controlled trial followed 23 patients who received near-infrared light therapy twice a week for five weeks. Over the following nine months, their T3, T4, and free T4 levels all increased significantly, and 22 of the 23 patients reduced their medication dose during that period. The most compelling long-term data comes from a six-year follow-up of 43 patients, which confirmed that the treatment remained safe over time, medication needs stayed lower, TPO antibodies stayed reduced, and thyroid volume and blood flow improved.
Treatment Protocol Used in Studies
The clinical trials that produced these results used a consistent protocol. The device was a continuous-wave diode laser emitting near-infrared light at 830 nm with an output power of 50 mW. Each point on the thyroid received about 40 seconds of exposure. Sessions happened twice per week for five weeks, totaling ten sessions as the initial course.
For home use, the parameters differ because consumer devices are LED panels rather than focused laser diodes. With an LED device, sessions typically last 10 to 20 minutes per treatment area. You can use the device several times per week. The key specifications to look for in a home device are wavelengths in the near-infrared range (830 to 850 nm) and, ideally, a combination with red light around 630 nm. A total irradiance of at least 25 mW/cm² is a reasonable baseline, which is what clinical-grade LED devices deliver.
How to Position the Device
Place the device 6 to 12 inches from the front of your neck, centered over the thyroid gland. The thyroid sits just below your Adam’s apple (or the equivalent spot in women), wrapping around the front of the windpipe in a butterfly shape. You want the light covering this area as evenly as possible. If your device has a small treatment head, you may need to move it slowly across both sides of the lower neck to cover the full gland.
Keep the device at a consistent distance throughout the session. Closer isn’t necessarily better, as too much energy density can reduce effectiveness (a phenomenon called the biphasic dose response, where moderate doses help but excessive doses don’t). If your device feels warm on the skin, pulling it back slightly is fine. The skin temperature shouldn’t exceed about 38°C (100°F).
What to Look for in a Home Device
Not all red light therapy panels are useful for thyroid applications. You need a device that emits in the near-infrared range, not just visible red light. Many consumer panels combine 630 nm (red) and 850 nm (near-infrared) LEDs, which covers both wavelengths used in research. A device with at least 60 near-infrared LEDs and a stated irradiance of 25 mW/cm² or higher at the recommended treatment distance will approximate what’s been studied clinically.
Smaller handheld devices can work if you’re patient enough to cover the thyroid area methodically. Larger panels designed for full-body use also work, though you’ll be paying for coverage area you don’t need for this specific purpose. The critical thing is verifiable specs: look for third-party irradiance testing or at minimum a manufacturer that lists exact wavelengths and power output rather than vague claims.
Who Should Avoid Thyroid Light Therapy
If you have hyperthyroidism (an overactive thyroid), avoid directing red or near-infrared light at your neck. The therapy stimulates cellular activity, which is the opposite of what an overactive gland needs. The same applies if you’re on medication for hyperthyroidism. Even if you’re using a light therapy device for skin concerns around your jaw or chin, steer clear of the thyroid area entirely.
People with thyroid cancer, a history of thyroid cancer, or undiagnosed thyroid nodules should not use light therapy on the neck. Because the therapy promotes cell growth and activity, it could theoretically accelerate abnormal cell proliferation. This applies to any active cancer or pre-cancerous condition in the treatment area.
Certain medications increase skin sensitivity to light, including some antibiotics, retinoids like isotretinoin, and common anti-inflammatory drugs. Conditions like lupus and porphyria also heighten light sensitivity. If any of these apply to you, the risk of skin reactions goes up. Pregnant women are generally advised to skip light therapy due to limited safety data, and it’s not well studied in children or teenagers whose bodies are still developing.
Realistic Expectations and Timeline
The clinical studies show measurable changes, but they take time. The initial treatment course in most trials lasted five weeks. Meaningful shifts in antibody levels and hormone production typically appeared within one to four months. The nine-month follow-up data suggests improvements can persist well beyond the active treatment period, and the six-year data confirms the effects can be durable.
That said, the research has involved relatively small groups of patients, mostly in the range of 20 to 43 participants per study. The results are consistent and encouraging, but this isn’t yet a therapy with the depth of evidence behind it that standard thyroid medications have. It works best as a complement to existing treatment rather than a replacement. If you’re taking thyroid medication, any dose adjustments should happen through regular blood work and your prescriber’s guidance, not on your own based on how you feel.